Elsevier, Medical Clinics of North America, 3(74), p. 837-850, 1990
DOI: 10.1016/s0025-7125(16)30556-9
Full text: Unavailable
Bacterial lung infections determine the prognosis for most cystic fibrosis patients. The antibacterial therapy is difficult because of the host-bacterium interaction and altered pharmacokinetics. The new insights in the working mechanisms of antibiotics that may lead to better treatment results have been discussed, and guidelines for treatment of lung infections in cystic fibrosis patients were given.